Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
This is a 50% increase over the number of companies inspected in the previous quarter, when four companies received four inspections.
Most of the companies inspected at the time were involved in the Drugs, Food and Cosmetics, and Veterinary sectors. The second most common type of company inspected worked in the Biologics sector.
All of the companies were in line with FDA regulations, and don't need to adjust their managing operations or regulatory/administrative actions.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
| Company Name | Area of Business | Inspection Date | Result |
|---|---|---|---|
| American Pasteurization Company, LLC | Food and Cosmetics | 03/21/2024 | No Action Indicated (NAI) |
| American Pasteurization Company, LLC | Veterinary | 03/21/2024 | No Action Indicated (NAI) |
| Cargill, Inc. | Veterinary | 01/24/2024 | No Action Indicated (NAI) |
| Cut Fresh, LLC | Food and Cosmetics | 01/30/2024 | No Action Indicated (NAI) |
| Hydrite Chemical Company | Drugs | 02/07/2024 | No Action Indicated (NAI) |
| Sterling Wisconsin, LLC | Drugs | 03/12/2024 | No Action Indicated (NAI) |
| Versiti Wisconsin, Inc. | Biologics | 03/04/2024 | No Action Indicated (NAI) |
Alerts Sign-up